Vema Hydrogen to Help Power California's Clean Energy Transition as a Qualified FPH2 Supplier Vema Hydrogen Recognized as a Qualified Supplier by the First Public Hydrogen Authority GlobeNewswire October 22, 2025 LOS ANGELES, Oct. 22, 2025 (GLOBE NEWSWIRE) — Today, Vema Hydrogen, developer of a disruptive renewable hydrogen production technology – Engineered Mineral Hydrogen(TM) – […]

Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million GlobeNewswire October 22, 2025 Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera's dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2)

Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream GlobeNewswire October 22, 2025 MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies

As Companies Clamor to Adopt AI, Culture and Trust Dictates Success, Says New “AI for All Index(TM)” from UKG's Great Place To Work New research underscores importance of HR and IT working together to drive AI adoption and avoid costly missteps. GlobeNewswire October 22, 2025 Oakland, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — At a

Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025 GlobeNewswire October 22, 2025 BOSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will

Axsome Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in November:

OTC Markets Group Welcomes Aviva PLC to OTCQX GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aviva PLC (LSE: AV; OTCQX: AVVIY, AIVAF), the UK's leading diversified insurer, has qualified to trade

Dorman's Complex Electronic Solutions Portfolio Expands With OE FIX(R) EPS Rack for Ram Trucks GlobeNewswire October 22, 2025 COLMAR, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Dorman Products, Inc. (NASDAQ:DORM) has released the aftermarket's first-ever, all-new electronic power steering (EPS) rack engineered to fit more than two million Ram pickup trucks. The EPS rack is

ECARX and Victory Giant Technology Announce Global Strategic Partnership GlobeNewswire October 22, 2025 LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) — ECARX (Nasdaq: ECX), a global mobility technology company, today announced its strategic cooperation with Victory Giant Technology (VGT), a world leader in the research and development, production, and sales of high-precision printed circuit boards (PCB),

Fidelity D & D Bancorp, Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire October 22, 2025 DUNMORE, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its unaudited, consolidated financial results for the three- and nine-month periods ended